基因表达时间延迟调控关系识别软件ITdGR

基因表达调控网络的深入研究有利于分子药物靶标的发现以及推新药的研发,是未来生物医学研究的重要内容。针对基因表达调控的时间延迟问题,我们初步设计开发了一套基于基因表达谱数据识别基因表达时间延迟调控关系的软件ITdGR(Identification of Time-delayed Gene Regulations)。并已经成功地将该软件应用于酿酒酵母细胞周期的基因表达谱数据中,识别出的调控关系与已有的知识相符。该软件为基因调控网络重构以及基因表达动态研究提供了一个方便和快捷的工具。     

基于多组学数据的肿瘤药物敏感性预测北大核心CSCD

肿瘤药物敏感性预测在指导患者临床用药方面具有重要意义。本文基于癌症药物敏感性基因组学数据库(genomics of drug sensitivity in cancer, GDSC) 198种药物的细胞系敏感性IC50数据,通过Stacking集成学习构建了包含基因表达、基因突变、拷贝数变异数据的多组学癌症药物敏感性预测模型。采用多种特征选择方法对基因特征进行降维,使用Stacking方法集成6种初级学习器和1种次级学习器进行建模,采用5折交叉进行模型验证。预测结果中AUC大于0.9的占比为36.4%,在0.8–0.9之间的占比为49.0%,最低AUC为0.682。基于Stacking构建的多组学预测模型较已有单组学和多组学模型的准确性和稳定性具有优势。多组学整合预测药物敏感性优于单一组学。特征基因功能注释和富集分析解析了肿瘤对sorafenib潜在的耐药机制,从生物学角度提供了模型可解释性及其应用于临床用药指导的价值。     

基于生物信息学方法发现潜在药物靶标

药物靶点通常是在代谢或信号通路中与特定疾病或病理状态有关的关键分子.通过绑定到特定活动区域抑制这个关键分子进行药物设计.确定特定疾病有关的靶标分子是现代新药开发的基础.在药物靶标发现的过程中,生物信息学方法发挥了不可替代的重要的作用,尤其适用于大规模多组学数据的分析.目前,已涌现了许多与疾病相关的数据库资源,基于生物网络特征、多基因芯片、蛋白质组、代谢组数据等建立了多种生物信息学方法发现潜在的药物靶标,并预测靶标可药性和药物副作用.     

基因表达谱微阵列网络数据库在肿瘤研究中的应用

基因表达谱微阵列数据库是一类可提供存储、查询、下载分析的在线网络数据库,在肿瘤相关领域的研究中提供了大量的数据来源。由于微阵列分析对于无生物/医学信息学专业背景的研究人员仍然有较多困难,致使该数据库的使用尚未普及。本文从数据查询、下载分析和使用方法等方面对常用基因表达谱微阵列数据库进行概述,并对现阶段基因表达微阵列数据库的应用策略进行总结,旨在帮助该领域研究的初学工作者了解数据库的基本知识并推动其在科研工作中的应用。     

整合转录组学数据的代谢网络研究进展

高通量测序技术的快速发展催生了涵盖各层次细胞生命活动的组学数据,如转录组学数据、蛋白质组学数据和互作组学数据等。同时,全基因组代谢网络模型在不断完善和增多。整合组学数据,对生物细胞的代谢网络进行更深入的模拟分析成为目前微生物系统生物学研究的热点。目前整合转录组学数据进行全基因组代谢网络分析的方法主要以流量平衡分析(FBA)为基础,通过辨识不同条件下基因表达的变化,进而优化目标函数以得到相应的流量分布或代谢模型。本文对整合转录组学数据的FBA分析方法进行总结和比较,并详细阐述了不同方法的优缺点,为分析特定问题选择合适的方法提供参考。     

LINCS——面向转化医学的细胞反应大数据计划

正近十几年来,基因芯片、转录组测序、蛋白质组等技术的发展是极大地推动了生物医学研究的重要手段.通过基因和蛋白质表达谱分析可以发现疾病发生与发展的关键分子、辅助辨识诊断标志物和药物治疗靶标.然而,传统的组学分析主要关注显著差异表达基因,由于噪声的影响,差异表达分析往往带来较多的假阳性.近年来,基因表达谱关联图谱分析逐渐成为基因表达谱分析的另一重要途径.基因表达谱关联图     

生命与健康大数据中心资源

生命与健康多组学数据是生命科学研究和生物医学技术发展的重要基础。然而,我国缺乏生物数据管理和共享平台,不但无法满足国内日益增长的生物医学及相关学科领域的研究发展需求,而且严重制约我国生物大数据整合共享与转化利用。鉴于此,中国科学院北京基因组研究所于2016年初成立生命与健康大数据中心(BIG Data Center, BIGD),围绕国家人口健康和重要战略生物资源,建立生物大数据管理平台和多组学数据资源体系。本文重点介绍BIGD的生命与健康大数据资源系统,主要包括组学原始数据归档库、基因组数据库、基因组变异数据库、基因表达数据库、甲基化数据库、生物信息工具库和生命科学维基知识库,提供生物大数据汇交、整合与共享服务,为促进我国生命科学数据管理、推动国家生物信息中心建设奠定重要基础。     

系统生物学研究中不同组学数据的整合

高通量实验方法的发展导致大量基因组、转录组、代谢组等组学数据的出现,组学数据的整合为全面了解生物学系统提供了条件.但是,由于当前实验技术手段的限制,高通量组学数据大多存在系统偏差,数据类型和可靠程度也各不相同,这给组学数据的整合带来了困难.本文以转录组、蛋白质组和代谢组为重点,综述了近年来组学数据整合方面的研究进展,包括新的数据整合方法和分析平台.虽然现存的数据统计和网络分析的方法有助于发现不同组学数据之间的关联,但是生物学意义上的深层次的数据整合还有待于生物、数学、计算机等各种领域的全面发展.     

时间延迟基因调控网络重构的决策树方法研究

基因调控网络的重构是功能基因组中最具挑战性的课题之一. 针对基因间转录调控的时间延迟性, 提出了一种寻找时间延迟调控关系的方法: 多点延迟调控网络算法, 简称TdGRN (time-delayed gene regulatory networking). 该方法根据时间序列基因表达谱数据, 构建时间延迟基因表达矩阵, 利用有监督决策树分类器方法和随机重排技术挖掘基因之间的时间延迟调控关系, 从而构建时间延迟的基因调控网络. 该方法是一种不依赖模型的基因网络重建方法, 相对于目前采用的基于模型的网络重建方法有显著优势, 可直接利用连续的基因表达谱数据发现延迟任一时间单位差的基因表达调控关系, 并避免了目前一些研究方法中需要人为设定基因的最大调控子数目(k)的问题. 将该方法应用于酿酒酵母细胞周期的基因表达谱数据, 并构建时间延迟的基因调控网络, 结果发现多数时间延迟调控关系获得了已有知识的支持.     

多组学整合网络: 一把精准解码玉米功能基因组的钥匙

高通量组学技术的快速发展使生命科学进入大数据时代。科学家们从基因组、转录组、蛋白质组和代谢组等多组学数据中剥茧抽丝, 逐步揭示生物体内复杂而巧妙的调控网络。近日, 华中农业大学李林课题组联合杨芳课题组和严建兵课题组构建了玉米(Zea mays)首个多组学整合网络。该网络包括3万个玉米基因在三维基因组水平、转录水平、翻译水平和蛋白质互作水平的调控关系, 由280万个网络连接组成, 构成1 412个调控模块。利用该整合网络, 研究团队预测并证实了5个调控玉米分蘖、侧生器官发育和籽粒皱缩的新基因。进一步结合机器学习方法, 他们预测出2 651个影响玉米开花期的候选基因, 鉴定到8条可能参与玉米开花期的调控通路, 并利用基因编辑技术和EMS突变体证实了20个候选基因的生物学功能。此外, 通过对整合调控网络的进化分析, 他们发现玉米两套亚基因组在转录组、翻译组和蛋白互作组水平上存在渐进式的功能分化。这套集合多组学数据构建的整合网络图谱是玉米功能基因组学研究的重大进展, 为玉米重要性状新基因克隆、分子调控通路解析和玉米基因组进化分析提供了新工具, 是解锁玉米功能基因组学的一把新钥匙。     

Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data

Background

Large-scale collaborative precision medicine initiatives (e.g., The Cancer Genome Atlas (TCGA)) are yielding rich multi-omics data. Integrative analyses of the resulting multi-omics data, such as somatic mutation, copy number alteration (CNA), DNA methylation, miRNA, gene expression, and protein expression, offer tantalizing possibilities for realizing the promise and potential of precision medicine in cancer prevention, diagnosis, and treatment by substantially improving our understanding of underlying mechanisms as well as the discovery of novel biomarkers for different types of cancers. However, such analyses present a number of challenges, including heterogeneity, and high-dimensionality of omics data.

Methods

We propose a novel framework for multi-omics data integration using multi-view feature selection. We introduce a novel multi-view feature selection algorithm, MRMR-mv, an adaptation of the well-known Min-Redundancy and Maximum-Relevance (MRMR) single-view feature selection algorithm to the multi-view setting.

Results

We report results of experiments using an ovarian cancer multi-omics dataset derived from the TCGA database on the task of predicting ovarian cancer survival. Our results suggest that multi-view models outperform both view-specific models (i.e., models trained and tested using a single type of omics data) and models based on two baseline data fusion methods.

Conclusions

Our results demonstrate the potential of multi-view feature selection in integrative analyses and predictive modeling from multi-omics data.

     

Use of gene networks for identifying and validating drug targets

We propose a new method for identifying and validating drug targets by using gene networks, which are estimated from cDNA microarray gene expression profile data. We created novel gene disruption and drug response microarray gene expression profile data libraries for the purpose of drug target elucidation. We use two types of microarray gene expression profile data for estimating gene networks and then identifying drug targets. The estimated gene networks play an essential role in understanding drug response data and this information is unattainable from clustering methods, which are the standard for gene expression analysis. In the construction of gene networks, we use the Bayesian network model. We use an actual example from analysis of the Saccharomyces cerevisiae gene expression profile data to express a concrete strategy for the application of gene network information to drug discovery.     

后基因组时代微生物天然产物高效发掘体系设计与展望

微生物天然产物具有丰富的化学结构多样性和诱人的生物活性,持续启迪着创新医药和农药的发现。近年来,随着高通量测序技术的快速发展,巨大的微生物基因组数据揭示了多样生物合成和新颖天然产物的潜能远高于以前的认知。然而,如何高效地激活隐性的生物合成基因簇 (BGCs) 并识别相应的化合物,以及避免已知代谢产物的重复发现等挑战依然严峻。本文描述了面对这些问题时基因组学、生物信息学、机器学习、代谢组学、基因编辑和合成生物学等新技术在发现药用先导化合物过程中提供的机遇;总结并论述了在潜力菌株优选、BGCs的生物信息学预测、沉默 BGCs的高效激活以及目标产物的识别和跟踪方面的新见解;提出了基于潜力菌株选择和多组学挖掘技术从微生物天然产物中高效发现先导结构的系统线路 (SPLSD),并讨论了未来天然产物药用先导发现的机遇和挑战。     

Towards precise reconstruction of gene regulatory networks by data integration

Background: More and more high-throughput datasets are available from multiple levels of measuring gene regulations. The reverse engineering of gene regulatory networks from these data offers a valuable research paradigm to decipher regulatory mechanisms. So far, numerous methods have been developed for reconstructing gene regulatory networks. Results: In this paper, we provide a review of bioinformatics methods for inferring gene regulatory network from omics data. To achieve the precision reconstruction of gene regulatory networks, an intuitive alternative is to integrate these available resources in a rational framework. We also provide computational perspectives in the endeavors of inferring gene regulatory networks from heterogeneous data. We highlight the importance of multi-omics data integration with prior knowledge in gene regulatory network inferences. Conclusions: We provide computational perspectives of inferring gene regulatory networks from multiple omics data and present theoretical analyses of existing challenges and possible solutions. We emphasize on prior knowledge and data integration in network inferences owing to their abilities of identifying regulatory causality.     

整合分析多组学数据筛选疾病靶点的精准医学策略

随着高通量测序技术的不断发展与完善,对于不同层次和类型的生物组学数据的获取及分析方法也日趋成熟与完善。基于单组学数据的疾病研究已经发现了诸多新的疾病相关因子,而整合多组学数据研究疾病靶点的工作方兴未艾。生命体是一个复杂的调控系统,疾病的发生与发展涉及基因变异、表观遗传改变、基因表达异常以及信号通路紊乱等诸多层次的复杂调控机制,利用单一组学数据分析致病因子的局限性愈发显著。通过对多种层次和来源的高通量组学数据的整合分析,系统地研究临床发病机理、确定最佳疾病靶点已经成为精准医学研究的重要发展方向,将为疾病研究提供新的思路,并对疾病的早期诊断、个体化治疗和指导用药等提供新的理论依据。本文详细介绍了基因组、转录组和表观组等系统组学研究在疾病靶点筛选方面出现的新技术手段和研究进展,并对它们之间的整合分析新策略和优势进行了讨论。     

Neural development in human embryonic stem cells-applications of lentiviral vectors

The derivation of neural lineages from human embryonic stem cells (hESCs) in vitro is based largely on exposure of hESCs to exogenous signals and substrates, designed to mimic conditions in the developing embryo. However, selection of specific lineages and the discovery of gene function in human neural development may be enhanced by the ability to intrinsically regulate gene expression. Recombinant lentiviral vectors provide an efficient method to stably introduce genes into hESC and their differentiating derivatives. Here we review the methods used to derive neural cells from hESCs, transduction of these cells with lentiviral vectors, and improvements that have been made to the vectors to enhance viral integration and transgene expression. Finally, we explore prospects for future uses of lentiviral vectors in hESC research, including their applications in library screening for drug development, zinc finger nucleases for gene editing and optogenetics to interrogate cellular pathways and function.     

Interpretation of network-based integration from multi-omics longitudinal data

Multi-omics integration is key to fully understand complex biological processes in an holistic manner. Furthermore, multi-omics combined with new longitudinal experimental design can unreveal dynamic relationships between omics layers and identify key players or interactions in system development or complex phenotypes. However, integration methods have to address various experimental designs and do not guarantee interpretable biological results. The new challenge of multi-omics integration is to solve interpretation and unlock the hidden knowledge within the multi-omics data. In this paper, we go beyond integration and propose a generic approach to face the interpretation problem. From multi-omics longitudinal data, this approach builds and explores hybrid multi-omics networks composed of both inferred and known relationships within and between omics layers. With smart node labelling and propagation analysis, this approach predicts regulation mechanisms and multi-omics functional modules. We applied the method on 3 case studies with various multi-omics designs and identified new multi-layer interactions involved in key biological functions that could not be revealed with single omics analysis. Moreover, we highlighted interplay in the kinetics that could help identify novel biological mechanisms. This method is available as an R package netOmics to readily suit any application.     

Homology-independent genome integration enables rapid library construction for enzyme expression and pathway optimization in Yarrowia lipolytica

Yarrowia lipolytica is an important oleaginous industrial microorganism used to produce biofuels and other value-added compounds. Although several genetic engineering tools have been developed for Y. lipolytica, there is no efficient method for genomic integration of large DNA fragments. In addition, methods for constructing multigene expression libraries for biosynthetic pathway optimization are still lacking in Y. lipolytica. In this study, we demonstrate that multiple and large DNA fragments can be randomly and efficiently integrated into the genome of Y. lipolytica in a homology-independent manner. This homology-independent integration generates variation in the chromosomal locations of the inserted fragments and in gene copy numbers, resulting in the expression differences in the integrated genes or pathways. Because of these variations, gene expression libraries can be easily created through one-step integration. As a proof of concept, a LIP2 (producing lipase) expression library and a library of multiple genes in the β-carotene biosynthetic pathway were constructed, and high-production strains were obtained through library screening. Our work demonstrates the potential of homology-independent genome integration for library construction, especially for multivariate modular libraries for metabolic pathways in Y. lipolytica, and will facilitate pathway optimization in metabolic engineering applications.